Novartis Drug Becomes First To Prevent Heart Attacks And Strokes By Targeting Inflammation

This morning, Novartis, the Swiss drug giant, announced that a drug that targets inflammation prevented heart attacks and strokes. It could be a scientific breakthrough, and a commercial one, too.
Source: Forbes.com Healthcare News - Category: Pharmaceuticals Authors: Tags: NYSE:NVS NYSE:AZN NYSE:SNY NASDAQ:REGN NASDAQ:AMGN Source Type: news